ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0945

A Single-cell Atlas of Human Synovial Endothelial Cells in Inflammatory Arthritis

Sam Edalat1, Reto Gerber2, Miranda Houtman1, Raphael Micheroli3, Kristina Buerki1, Nadja Izanc1, Blaz Burja4, Tadeja Kuret5, Snežna Sodin-Šemrl5, Adrian Ciurea3, Oliver Distler3, Caroline Ospelt1, Chantal Pauli6, Mark Robinson7 and Mojca Frank-Bertoncelj3, 1Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland, 2Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich and Department of Molecular Life Sciences and SIB Swiss Institute of Bioinformatics, University of Zurich, Zurich, Switzerland, 3Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich/University of Zurich, Zurich, Switzerland, 4Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich and Department of Rheumatology, University Medical Centre Ljubljana, Zurich, Switzerland, 5Department of Rheumatology, University Medical Centre Ljubljana, Ljubljana, Slovenia, 6Department of Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland, 7Department of Molecular Life Sciences and SIB Swiss Institute of Bioinformatics, University of Zurich, Zurich, Switzerland

Meeting: ACR Convergence 2021

Keywords: Bioinformatics, genomics, rheumatoid arthritis, Spondyloarthropathies, Synovitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 7, 2021

Title: Abstracts: Spondyloarthritis Including PsA – Basic Science (0944–0947)

Session Type: Abstract Session

Session Time: 9:15AM-9:30AM

Background/Purpose: Dysregulated endothelial cell (EC) function and altered (lympho)angiogenesis crucially contribute to synovial pathology in inflammatory arthritis. Additionally, endothelium plays a key role in the positional identity of sublining synovial fibroblasts and their pathogenic expansion in RA. Here, we utilized single-cell RNA sequencing (scRNA-seq) to characterize the diversity of synovial vascular and lymphatic ECs and functionally annotate synovial ECs across inflammatory arthritides.

Methods: We obtained synovial tissue from 12 knees, 8 wrists, 8 metacarpophalangeal and one sternoclavicular joint from 14 RA, 5 SpA, 3 PsA and 3 patients with undifferentiated arthritis (UA, 2 mono-, 1 polyarthritis) using ultrasound-guided synovial biopsy. We dissociated synovium into a single cell suspension through a combined mechanical-enzymatic dissociation. Additional tissue was formalin-fixed and paraffin-embedded for immunohistology (Krenn synovitis score, pathotype). We created scRNA-seq libraries with 10x Genomics Chromium and sequenced them on NovaSeq6000 (min. 50’000 reads/cell). We mapped the reads to the reference genome GRCh38.p13 (transcripts from GENCODE Release 32) and analysed the scRNA-seq data with R/Bioconductor tools, including quality control, filtering, graph-based clustering, manual and computational cell-type annotation, differential abundance (DA), and differential state analysis. We visualized data using iSEE.

Results: Our dissociation protocol yielded highly viable (median 90%) single-cell suspensions from which we generated 107’438 high quality synovial single cell profiles. We could classify synovial pathotypes in 86% of the samples (24% diffuse myeloid, 29% lympho-myeloid, 33% pauci-immune). Krenn synovitis score ranged from 2 to 8 (median 4), suggesting a moderate inflammation in most synovia. ScRNA-seq analysis identified 6 principal and 4 minor synovial cell populations forming 38 distinct synovial cell clusters (Fig 1A). PECAM1+ ECs (n=10’231) represented 4-15% (25Q-75Q, median 9%) of all synovial cells, comprising 8 distinct cell subpopulations: ACKR1high SELEhigh ICAM1high IL6+ venous ECs, ACKR1high SELEhigh IL6– venous ECs, ACKR1high SELElow IL6– venous ECs, COL3A1+ and COL3A1– SPARChigh KDR+ PLVAPhigh capillary ECs, highly proliferative TOP2A+ ECs, CLDN5+ PODXL1+ TJP4+ arterial ECs and lymphatic LYVE1+ PROX1+ CCL21+ ECs (Fig 1B). EC subpopulations were heterogeneously distributed across patients (Fig 1C), but none of the EC subpopulations was significantly enriched in RA, PsA and SpA synovia in our patient cohort. We defined synovial pan-endothelial and subtype-specific EC markers (Fig 1D) and identified genes that infer the core EC subtype-specific functions (Fig 1E).

Conclusion: We created a comprehensive single-cell atlas of synovial ECs in patients with inflammatory arthritis. Our EC dataset comprises more than 10’000 EC profiles, representing a reference dataset for annotating synovial ECs and guiding EC subtype-specific functional studies.

Figure 1. ScRNA-seq: UMAP plots with annotations of (A) all synovial cells and (B) ECs. (C) A heterogeneous distribution of the eight EC subpopulations across patients with PsA, RA, SpA and UA. The EC subpopulations are specified with the colour palette. (D) Top 10 cluster marker genes per each of the eight EC subpopulations. The EC subpopulations are specified with the colour palette at the top of the heatmap. (E) Core enriched genes in EC subpopulations inferring EC functions.


Disclosures: S. Edalat, None; R. Gerber, None; M. Houtman, None; R. Micheroli, Gilead Sciences, 2, Eli Lilly, 2, Pfizer Inc, 2, AbbVie, 2; K. Buerki, None; N. Izanc, None; B. Burja, None; T. Kuret, None; S. Sodin-Šemrl, None; A. Ciurea, AbbVie, 6, Eli Lilly, 6, MSD, 6, Novartis, 6, Pfizer Inc, 6; O. Distler, AbbVie, 12, Project scoring fee for Rheumatology Grant, Amgen, 2, Eli Lilly, 2, Pfizer Inc, 2; C. Ospelt, Novartis Foundation for Biomedical Research, 5; C. Pauli, None; M. Robinson, None; M. Frank-Bertoncelj, AbbVie, 5.

To cite this abstract in AMA style:

Edalat S, Gerber R, Houtman M, Micheroli R, Buerki K, Izanc N, Burja B, Kuret T, Sodin-Šemrl S, Ciurea A, Distler O, Ospelt C, Pauli C, Robinson M, Frank-Bertoncelj M. A Single-cell Atlas of Human Synovial Endothelial Cells in Inflammatory Arthritis [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/a-single-cell-atlas-of-human-synovial-endothelial-cells-in-inflammatory-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-single-cell-atlas-of-human-synovial-endothelial-cells-in-inflammatory-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology